|Description||N-[(4-Aminophenyl)methyl]adenosine is a adenosine receptor inhibitor with Ki value of 29 nM for Rat ecto-5′-Nucleotidase.|
|Solubility||10 mM in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Boiling Point||749.0±70.0 °C | Condition: Press: 760 Torr|
|Density||1.71±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
N6-Cyclohexyladenosine is a derivative of Adenosine, a selective A1 receptor agonist with EC50 = 8.2 nM.
Capadenoson is a potent and selective adenosine A1 receptor agonist, which is a powerful protective mechanism in cerebral.
UP202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). It was found to be an allosteric enhancer of Emax. It exerted an Emax-enhancing effe...
N6-(2-Phenylethyl)adenosine is a selective A1 adenosine receptor agonist with anti-proliferative activity on bladder cancer cells.
Theophylline is a methylated xanthine derivative; that functions as a nonselective PDE4 inhibitor and nonselective adenosine receptor antagonist.
Sonedenoson is an adenosine A2 receptor agonist under the development of King Pharmaceuticals Research and Development. It can effectively promote rapid wound h...
Naxifylline, a xanthine derivative, has been found to be an adenosine A1 receptor antagonist as well as diuretic agent that was once studied in heart failure an...
Non-specific inhibitor of cAMP and cGMP phosphodiesterases. The increase in cAMP level as a result of phosphodiesterase inhibition by IBMX activates PKA leading...
Adenosine A2 receptor antagonists; Immunosuppressants
GP531 is a novel riboside with similar structural and anti-ischemic properties to the adenosine-regulating agent (ARA) acadesine.
412348 is an adenosine A2A receptor antagonist with anti-Parkinsonian activity in both rodent andprimate animal models. Because of its high affinity for the ade...
KFM19 is a selective adenosine A1-antagonist with good bioavailability (IC50= 50 nM).
Trabodenoson is a selective adenosine A1 receptor agonist. Trabodenoson can significantly reduce IOP in glaucoma and OHT patients. Phase III clinical trials for...
CPI-444 is a potent, orally available, selective antagonist of the adenosine A2A receptor that has been well tolerated in Ph 1/1b studies in non-oncology indica...
Valsartan is a selective angiotensin II receptor antagonist, used to treat high blood pressure and congestive heart failure.
KW-3902 is a selective adenosine A1 receptor antagonist under the development of Kyowa Hakko and Merck & Co. It displays 890-fold selectivity for rat A1 recepto...
Ticlopidine HCl is an P2 receptor inhibitor against ADP-induced platelet aggregation with IC50 of ~2 μM.
ASP-5854 is an adenosine A1 and A2A receptor antagonist receptor. It has therapeutic potential for the treatment of Parkinson's disease to ameliorate motor defi...
CF101 is a specific agonist to the A3 adenosine receptor, which inhibits the development of colon carcinoma growth in cell cultures and xenograft murine models...